Italy· 046503049

QUILOGA

A rosuvastatin and ezetimibe product containing rosuvastatina + ezetimibe, registered in Italy by ZENTIVA K.S., on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC C10BA06

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedQUILOGAATCC10BA06REGISTER NO.046503049PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Rosuvastatin and ezetimibe is registered in 9 of 19 countries.

Countries holding a registration under ATC C10BA06 (rosuvastatin and ezetimibe), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 7 of them publish a price we can compare per daily dose

Rosuvastatin and ezetimibe · ATC C10BA06

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AIFA (Italy)
Active substance
Rosuvastatina + Ezetimibe
Manufacturer
ZENTIVA K.S.
Country
Italy (IT)
ATC code
C10BA06
ATC class
Rosuvastatin and ezetimibe
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    046503049
    "10 MG/10 MG COMPRESSE" 30 COMPRESSE IN BLISTER PA/AL/PVC/AL
    EUR 10.7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rosuvastatin and ezetimibe in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rosuvastatin and ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Arosuva Plus Ezetimib, Ezerosu
  • Belgium · Cholecomb, Ezetimibe/Rosuvastatin Sandoz
  • Bulgaria · Rosteza 10 Mg/10 Mg, Rosteza 20 Mg/10 Mg
  • Cyprus · Celmantin Plus, Lipocomb
  • Czechia · Delipid Plus, Refidoro
  • Germany · Antilia, Ezehron Duo
  • Estonia · Delipid Plus, Rosazimib
  • Spain · Alzil Plus, Arrox Plus
  • Finland · Rosuvastatin/Ezetimib Krka, Rosuvastatin/Ezetimibe Ratiopharm
  • France · Liporosa, Quiloga
  • Greece · Celmantin Plus, Co-Rosuvador
  • Croatia · Arosen, Co-Roswera
  • Hungary · Co-Xeter, Delipid Plus
  • Ireland · Lipocomb, Rosuvastatin/Ezetimibe Krka
  • Lithuania · Roselia, Sorvitimb
  • Luxembourg · Cholecomb, Myrosor
  • Latvia · Rosazimib, Rosulip
  • Malta · Ezehron Duo, Lipocomb
  • Netherlands · Ayadont, Cholecomb
  • Norway · Rosteze, Rosuvastatin/Ezetimib Krka
  • Poland · Coroswera, Ezehron Duo
  • Portugal · Colroset, Lipocomb
  • Romania · Co-Roswera, Lipocomb
  • Slovenia · Refidoro, Rozor
  • Slovakia · Lipocomb, Rosazimib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be505307-aca8-4fbb-97f4-3d61ad3980f1
GET /v1/drugs/be505307-aca8-4fbb-97f4-3d61ad3980f1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"10 MG/10 MG COMPRESSE\" 30 COMPRESSE IN BLISTER PA/AL/PVC/AL",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Rosuvastatina + Ezetimibe",
  "reference_pack": "30 UNITA' 10+10 MG - USO ORALE",
  "public_price_eur": 10.7,
  "ssn_reference_price_eur": 10.7
}

See everything about rosuvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.